Wednesday, 28 April 2021
Investor Ideas #Potcasts 558, #Cannabis News and #Stocks on the Move; (CSE: $XTRX.C) (TSX: $VLNS.TO) (OTC: $HCANF) (CSE: $TRIP.C) (TSXV: $N.V) (NYSE: $HEXO)
Investor Ideas #Potcasts
558, #Cannabis News and #Stocks on the Move; (CSE: $XTRX.C) (TSX: $VLNS.TO)
(OTC: $HCANF) (CSE: $TRIP.C) (TSXV: $N.V) (NYSE: $HEXO)
Delta, Kelowna, BC, April 28, 2021 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/042821-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/04281XTRX-VLNS-HCANF-TRIP-HEXO.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s
podcast is sponsored by Phyto
Extractions Inc. (CSE:XTRX), an
agricultural-scale cannabis extraction, distillation and product manufacturer
located in Langley, BC at its co-located Health Canada Licensed Standard
Processing (extraction, no cultivation), Sales (extracts, topicals, and
edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through
Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D
license amendment.
In
today’s podcast we look at a few public company announcements.
The
Valens Company Inc. (TSX:
VLNS) (OTCQX:
VLNCF), a leading manufacturer of cannabis products,
announced that it has entered into a definitive agreement to
acquire all of the issued and outstanding shares of Green Roads and its majority owned manufacturing subsidiary
(collectively, "Green Roads") in a cash and share transaction for
closing consideration of US$40 million, plus up to an additional US$20 million
in contingent consideration payable upon the business achieving certain EBITDA
milestones.
With the Acquisition of Green Roads,
The Valens Company strengthens its capabilities to supply US domestic and
global markets with an expanded product offering. Additionally, the Acquisition
provides immediate entry into the US market with a trusted and leading CBD
health and wellness brand with an established manufacturing and distribution
platform. The Green Roads Acquisition is expected to be accretive to the
Company in 2021. If all the Milestones are met in 2022, the transaction
represents approximately 4.5x fiscal 2022 EBITDA. On a pro forma basis, the
combination of Valens and Green Roads results in a business which generated
total revenue of C$111.6M in 2020.
Green Roads is the largest
privately-owned CBD company in the United States, with a focus on quality from
its pharmacist-founded background. Based in South Florida, the company produces
an award-winning lineup of health and wellness products using hemp-derived CBD
across a variety of consumer categories such as oils, topicals, ingestibles,
personal care and pet products. Additionally, Green Roads provides B2B
manufacturing services for a variety of partners. Green Roads boasts a leading
market share and brand platform in the US CBD industry, with an extensive
distribution network consisting of over 7,000 retail stores and a robust
e-commerce and marketing platform with over 30,000 five-star reviews across all
its product lines. Similar to The Valens Company, Green Roads holds a deep
commitment to quality control and consumer transparency, producing
pharmacist-driven proprietary formulations that result in only the highest
quality consumer products. Green Roads is currently one of a small number of US
CBD companies that produce their products in their own cGMP facilities, a
testament to their dedication to integrity and excellence.
Tyler Robson, Chief Executive
Officer, Co-Founder and Chair of The Valens Company, said: "After
analyzing over a hundred companies across the US CBD market, we clearly
recognized the value in the Green Roads platform with its best-selling brand.
Our complementary businesses, culturally aligned teams, and shared 'it's
personal' mission to provide consumers with high quality, innovative cannabis
products led to an undeniable combination that we believe will disrupt the
industry. The acquisition of Green Roads represents only the first step in our
US expansion strategy as we expect to continue to unlock complementary,
revenue-generating opportunities while we forge our presence and build our
reputation in the world's largest cannabinoid market. Together, The Valens
Company and Green Roads make a formidable team, and the combined entity will be
primed for significant growth as the global market develops."
Valens
also announced that it
has submitted an initial application to list its common shares on the Nasdaq
Capital Market.
"We
have taken a significant step forward in achieving one of our main goals for
2021 by filing our initial application for listing on the Nasdaq on the back of
announcing our first acquisition in the US," said Jeff Fallows, President
of The Valens Company. "We believe that listing in the US will unlock
various opportunities to enhance corporate visibility, increase liquidity and
broaden overall awareness of The Valens Company to a larger investor base while
driving value for our shareholders."
The
listing of the Company's Shares remains subject to the review and approval by
Nasdaq of the Company's listing application and the satisfaction by the Company
of all applicable listing, governance and regulatory requirements. In
connection therewith, the Company expects to ask shareholders of the Company to
approve a consolidation of the Shares at the next annual and special meeting of
Shareholders scheduled for May 25, 2021. If the share consolidation is approved
at the Shareholder Meeting, the Company believes that it will meet the
requirements for listing on the Nasdaq shortly thereafter, including Nasdaq's
financial and liquidity requirements. Further details of the proposed share
consolidation will be contained in the management information circular of
Valens mailed to Shareholders and to be filed shortly on SEDAR at www.sedar.com.
The
Company currently expects that Nasdaq will make a decision on the Company's
application by the end of June 2021. The Shares will continue to be listed on
the Toronto Stock Exchange under the symbol "VLNS". In addition to
the Company's primary listing on the TSX, the Shares will continue to be quoted
on the OTCQX until such time as the Shares may be listed on the Nasdaq, if the
Company's listing application is approved.
Valens
has retained Stikeman Elliott LLP in Canada and Foley Hoag LLP in the US as
legal counsel to advise the Company throughout the application process.
Further to the joint press release
dated November 19, 2020, Halo Collective
Inc. (NEO:
HALO) (OTC:
HCANF) and Red Light
Holland Corp. (CSE:
TRIP) (OTC:
TRUFF) announced that
Articles of Incorporation have been filed with the Oregon Secretary of State to
form Red Light Oregon, Inc., a 50/50 joint venture between Halo and Red Light
Holland. The JV will be capitalized with US$50,000 from each party, and its
initial directors will be Todd Shapiro, Red Light Holland Director and CEO,
Sarah Hashkes, Red Light Holland Chief Technology and Innovation Officer, Kiran
Sidhu, Halo CEO and Director, and Katie Field, Halo President. The JV will
monitor ongoing regulatory updates regarding Oregon's Measure 109, appoint a
management team, and develop a commercialization strategy in due course.
"We are delighted to take this
next step with Halo. We now have the entity and team in place to begin laying
the groundwork for potential future participation in the Oregon Psychedelic
Magic Mushroom market." Said Todd Shapiro, CEO, and Director of Red Light
Holland. "Kiran and his team have extensive experience working with Oregon
regulators, and we could not be more excited to have them as a partner! We also
plan on continually monitoring other future markets opening in the USA as the movement,
both socially and from a therapeutic/medicinal level promoting the acceptance
of psilocybin via legal, policy and regulatory measures rapidly progress."
"We have been diligently
studying the anticipated market growth for psychedelic products and the potential
benefits for consumers. Now that Governor Brown appointed a board to oversee
Oregon's rollout of psylocibin, Halo, and Red Light decide to take the next
step towards implementing our joint venture. Todd is a visionary, and we are
thrilled to be working with him and his team to make our dream of manufacturing
and serving consumers with these new therapies a reality. The addition of Sarah, Red Light's CTO, to
the Board will enable us to stay ahead of the curve utilizing her background in
cognitive neuroscience research, immersive technology to develop psychedelic
products and consumer offerings. Stay tuned for more updates."
Further details will be announced
once available and as the contours of the Oregon regulated market begin to take
shape.
HEXO Corp (TSX:
HEXO) (NYSE:
HEXO)
today announced that its flagship Masson-Angers
cultivation campus has received its Control Union Medical Cannabis Standard
GACP (“CUMCS-GACP”) certification, the leading certification standard for
medical cannabis cultivation.
“Receiving
the CUMCS-GACP certification is a testament to the team’s attention to detail
and commitment to producing high-quality, consistent cannabis products to serve
the global cannabis industry,” said Sebastien St-Louis, HEXO CEO and
co-founder. “As we continue to go after additional market share in Canada, and
to penetrate new markets around the world, this certification demonstrates that
we continue to offer high-quality output our current and future CPG partners
can count on.”
The
CUMCS-GACP certification represents a standard of quality and consistency for
cannabis propagation, cultivation and post-harvest processes and is compliant
with both the World Health Organization and European Medicines Agency Good
Agricultural and Collection Practice guidelines.
Namaste
Technologies Inc. (TSXV:
N)
(OTC:
NXTTF) a marketplace platform for cannabis and wellness
products, announced that CannMart.com
has now been launched in french for the province of Quebec and across Canada.
The Company also provides a further corporate update.
The
Company announced that it has now launched a new french website for
CannMart.com that will offer medical products to customers across the province
of Quebec which is the second largest province in Canada and all francophones
in Canada in the language of their choice. Of particular note is that at
CannMart.com, Quebec residents qualifying for medical cannabis have access to
certain cannabis products not otherwise available in the adult recreational
market including edibles and vape cartridges. The Quebec cannabis market is
sizable, with reported cannabis sales in the adult use recreational market
alone for the three month period ending January 2, 2021 reaching in excess of
$170 million as reported by the legislated monopoly holder for recreational
cannabis sales within the province of Quebec.
This
announcement marks an important step in CannMart.com’s commercial expansion,
following months of building its portfolio and taking the necessary strategic
measures to ensure proper supply of inventory. Staff have been hired from
Quebec who are fully bilingual to offer customers an excellent experience with
customers across Canada continue to enjoy the convenience of having their
medical cannabis delivered directly to their home in a safe and convenient way.
Namaste
also advised that it's wholly owned subsidiary CannMart Labs Inc. has engaged
CannDelta with respect to its application for a Health Canada Controlled Drugs
and Substances Dealer’s Licence for distribution of controlled substances such
as psilocybin and psilocin. Namaste anticipates submission of the application
by the end of May this year. Projected timeline for receipt of approvals is by
the beginning of fiscal third quarter of 2022. Subject to Health Canada
acceptance, a Dealer’s Licence could allow Labs to engage in a number of
activities relating to the controlled substances referenced including the
research and distribution of controlled substances and the sale of controlled
substances to researchers and companies undertaking clinical trials.
The
Company would also like to invite shareholders and guests to participate in
attending a virtual town hall so they can hear a presentation on the progress
made by the Company.
● Thursday,
May 6, 2021
● 12:00
p.m. EST
● Presentation
by Meni Morim followed by Q&A
● All
Shareholders are invited to submit their questions by May 3rd to:
ir@namastetechnologies.com. Our CEO, Meni Morim, will answer submitted
investors questions during the town hall event.
● Shareholders
can access the event using the following link: http://bofc.me/may6townhall
Once
again, today’s podcast is sponsored by Phyto
Extractions Inc. (CSE:XTRX), an
agricultural-scale cannabis extraction, distillation and product manufacturer
located in Langley, BC at its co-located Health Canada Licensed Standard
Processing (extraction, no cultivation), Sales (extracts, topicals, and
edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through
Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D
license amendment.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google Play
Music and most audio platforms available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and
equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
#Cannabis 2.0 is Really Here – #Stocks to Watch (CSE: $XTRX.C) (TSX-V: $RTI.V) (TSX: $VLNS.TO) (CSE: $OILS.C) @adastra_labs @RadientInc @TheValensCo @nextleaf_oils
#Cannabis 2.0 is
Really Here – #Stocks to Watch (CSE: $XTRX.C) (TSX-V: $RTI.V) (TSX: $VLNS.TO)
(CSE: $OILS.C) @adastra_labs @RadientInc @TheValensCo @nextleaf_oils
New
Distribution and R&D Bolster Extract Capabilities
Point
Roberts WA, Delta, BC –April 28, 2021 - Investorideas.com, a
leading investor news resource covering cannabis and hemp stocks releases a
special report on the accelerated growth within the extracts and “Cannabis 2.0”
categories as more companies further distribution and expand R&D
capabilities, featuring Phyto
Extractions Inc. (formerly Adastra
Labs Holdings Ltd.) (CSE:XTRX).
Read this article,
featuring XTRX in full at https://www.investorideas.com/news/2021/cannabis/04281XTRX-RTI-VLNS-OILS.asp
The global cannabis extract market
size was valued at USD 7.3 billion in 2019 and is anticipated to register a
CAGR of 16.6% over the forecast period to 2027 says Grandview Research.
One company set to capitalize on this extract growth is Phyto Extractions Inc. (formerly Adastra Labs Holdings Ltd.) (CSE:XTRX). Phyto Extractions™ is an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction and products, no cultivation), Sales (extracts, topicals and edibles) and R&D through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc.
According to Phyto Extractions
news, “The current cannabis extract market has seen a huge
boom in sales from the past year, in which demands for cannabis extracts are
rising steadily. Canadian cannabis extract sales observed an exponential 315%
growth rate for the past two years, from 320,201 non-medical sales in Oct. 2019
to 1,328,769 sales in Oct. 2020, and over 200% sales growth rate including all
medical and non-medical sales. Rising demand for cannabis extract products
requires reasonable supplies from producers for cannabis enthusiasts.”
The Company recently announced that it
has received its Health Canada R&D license addendum in Adastra Labs Inc.
that will permit some limited human testing by licensed researchers
administering or distributing cannabis to human research subjects using
cannabis obtained from a holder of a license for processing in the final form
of cannabis.
This R&D license addendum will
permit the Company to conduct in-house human testing for taste of various
cannabis products for assessment of taste, sights, smell, or touch of cannabis.
"We look forward to initiating
human-studies and generating valuable consumer-based data to support our
product development pipeline and continue delivering high-quality efficacious
cannabis products to Canadians," stated Dr. Kyle Boniface, PhD.
The Company also announced
on April 21st they are now
producing cannabis shatter products for the Canadian market after wholly-owned
subsidiary Adastra Labs Inc.'s commissioning of new hydrocarbon extraction
equipment ahead of schedule.
From the news: “With the arrival of
the ExtractionTek Solutions MeP XT70 system, a high-performance hydrocarbon
extractor, the team at Phyto Extractions can now process over 400 KG per day of
cannabis biomass into a variety of hydrocarbon cannabis concentrate products.
Focused on shatter production currently, this translates into over 50kg of
high-quality product output per day.”
From the news: “Phyto Extractions™
has launched three new shatter cannabis products: Pink Kush, Blue Gorilla OG,
and D. Bubba that will serve the over 9 million Canadians currently in the
cannabis market with its one-gram offerings. The Company's increasing market
share in the disposable vape, vape cartridge, and live resin markets,
strengthens the brand's launch of its new flagship 'shatter' product line.”
From the news: “With relatively few
players in the niche of shatter product space in Canada, this market expansion
represents a significant opportunity given the forecasted growth of the
Cannabis extract market.”
Shatter video: https://youtu.be/Bo4VWLSAT7o
Radient
Technologies Inc. (TSX-V:
RTI)
(OTCQX:
RDDTF), a cannabis
company utilizing a proprietary extraction and downstream processing platform, in
December 2020 announced its
licensing agreement with Tunaaaaroom to manufacture and distribute a wide range
of premium cannabis extracts targeting recreational cannabis consumers in
Canada. Radient will make use of its Health Canada Cannabis Research and
Analytical Testing licenses to fully characterize the Tunaaaa strains and
evaluate the sensory qualities of extracts formulated to mimic the specific
terpene profiles and containing differing cannabinoid profiles and potencies.
Based in Edmonton, Tunaaaa has spent
over six years developing the genetics for over 1,000 high-quality cannabis
strains containing proprietary terpene profiles. Through this licensing deal,
Radient will gain access to Tunaaaa’s specific genetics and will engage the
Tunaaaa breeders as consultants to help drive product development.
Radient will further make use of its
Standard Processing and Sales Licenses to rapidly launch premium distillate dab
and vape extracts. Radient plans to bring Tunaaaa’s vast catalogue of unique
flavours to the market with monthly drops of new terp profiles. Radient and
Tunaaaa will also work in collaboration on CBD and CBN distillate dabs to
create additional unique terpene extract products for recreational cannabis
consumers.
Future Radient extract products may
include Cannabis 2.0 products like diamond, shatter, caviars, live rosin, terp
sauce as well as micro cannabinoid isolates and edibles.
The
Valens Company Inc. (TSX:
VLNS) (OTCQX:
VLNCF), a leading manufacturer of cannabis products,
specifically in the Cannabis 2.0 product category recently
announced expansion of its distribution in both Manitoba and the
Yukon, having entered into an agreement with the Manitoba Liquor &
Lotteries Corporation to supply and distribute a wide range of cannabis
products to LGCA-licensed private retailers in the Province of Manitoba, as
well as its entry into the Yukon market with a cannabis purchase and sale
agreement with the Yukon Liquor Corporation (YLC). With this agreement, Valens
expands its distribution network to five provinces in the country.
"Expanding our domestic
distribution capabilities is one of our top strategic initiatives to drive
growth this year and beyond," said Tyler Robson, Chief Executive Officer,
Co-Founder and Chair of The Valens Company. "Our entry into the Manitoba
market takes us a step further toward capturing larger market share and
bringing the Valens advantage to consumers in a new province, enabling greater
access to our high-quality products across Canada."
"Our entry into the Yukon
market not only furthers our ability to capture market share in Canada, but
also broadens the selection and quality of products that consumers in the
territory can access," continued Tyler Robson. "We have made
significant progress growing our cannabis distribution network and we expect to
increase our national position in the short-term as we continue discussions
with other private and government-regulated retailers across the country."
Valens has already shipped several
products to the province, including A1 Cannabis' Summit 10 THC beverages, Verse
Cannabis' Tropic Lemon and Sunset Peach vape carts and 1:20 CBD oil, with
additional product formats across various categories expected to be shipped in
the coming weeks.
Nextleaf
Solutions Ltd. (CSE:
OILS) (OTCQB:
OILFF), the world's most innovative cannabis processor, announced in
March, 2021 that it has commenced human trials of cannabis vapes.
Under its amended Cannabis Research
Licence from Health Canada, Nextleaf is collecting sensory evaluation data from
qualified volunteers completing organoleptic assessments of a wide variety of
formulated cannabis vape products. The Company is comprehensively testing a
range of cannabinoid and terpene formulations, including how various vape
hardware interacts with different formulations. Nextleaf expects to accelerate
product development and drastically shorten design cycles for launching new
cannabis vape products by validating formulations and delivery technologies
more efficiently.
Forbes wrote a feature around
Nextleaf's human trial program on March 30, 2021 and the article can
be read here.
"The amended Cannabis Research
Licence allows Nextleaf to rapidly formulate a wide variety of cannabis
products and administer samples to volunteer research participants," said
Nextleaf Solutions R&D Lead, Dr. David Novitski. "The ability to
provide commercial partners with data-based consumer insights around taste and
overall user experience is a true game changer for product development."
Since becoming legal in Canada,
vapes have emerged as the clear leader of all cannabis 2.0 products. According
to the most recent data from the Ontario Cannabis Store, the vape category
ranks second only to dried flower with 15.7% of all Ontario cannabis sales. In
more mature adult-use markets like Colorado, Oregon, and Washington, the market
share for cannabis vapes reached as high as 22.3%, according to data from
Headset. As Canada continues to roll out brick and mortar cannabis retail
stores, the vape segment is expected to continue to increase in overall size
and market share. The Company believes the CBD vape subcategory could see
significant growth should Health Canada regulations change to allow for
increased legal access to CBD products. Nextleaf plans to validate its
proprietary CBD vape technology under its amended Cannabis Research Licence.
Collecting data-based consumer
insights is particularly important in an increasingly competitive market in
which initial product launches can dictate the long-term success of a brand.
"There are a lot of subpar vape
products available in the market today that have not gone through rigorous
testing and human trials," said Nextleaf Solutions CEO Paul Pedersen.
"Issues such as poor taste, clogging, leaking, and crystallization in CBD
vapes are well documented throughout the industry. Collecting consumer feedback
during product development is key to launching differentiated cannabis 2.0
products that provide consumers with a positive experience and value."
Considering the recent cannabis
investments by large pharmaceutical and tobacco companies, it is apparent that
generating and protecting intellectual property is becoming more important in
the next phase of the industry's maturation. Management believes Nextleaf is
well positioned with its product innovation pipeline and success securing
issued patents in the United States. Nextleaf owns 12 US patents and has been
issued over 70 patents globally. Innovation is core to Nextleaf's value
proposition, and its ability to differentiate with its patented and patent
pending cannabinoid delivery technologies and formulations. The amended
Cannabis Research Licence allows Nextleaf to continue to develop, validate, and
strengthen its R&D within a federally legal market.
As we see more extract companies
expanding their R&D and distribution capabilities, we see a three-fold gain
to the industry. This will create accelerated growth and competition in the
category, higher quality products for consumers which will be more effective
through proper research, as well as important industry data points through
having access to proper research techniques which can have a massive benefit to
both the medical and recreational market moving forward.
As both the Canadian and US cannabis
industries begin to enter into a state of maturation and stability we see the
Cannabis 2.0 product category continue to gain a larger sales footing which can
only be expected to grow further as consumer awareness rises along with product
consistency and availability.
About
Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third
party news, research and original financial content. Learn about investing in
stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining,
sports biotech, water, renewable energy and more. Investor Idea’s original
branded content includes the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move
podcast and column, Cleantech
and Climate Change , Exploring
Mining
the AI
Eye .
Disclaimer/Disclosure: Our site does not make recommendations for purchases or sale of
stocks, services or products. Nothing on our sites should be construed as an
offer or solicitation to buy or sell products or securities. All investing
involves risk and possible losses. This site is currently compensated for news
publication and distribution, social media and marketing, content creation and
more. Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions. Disclosure:
this news article featuring XTRX is a paid for news release on
Investorideas.com (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact
Investorideas.com
800-665-0411
Get more Cannabis Stock
Investor Ideas - news, articles, podcasts and stock directories
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...